Clinical Trial Update: A Study of Pembrolizumab in Combination With Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma (MPM) (MK-3475-A17) [Phase 1]

View source ↗

Summary

Phase 1 study of pembrolizumab in combination with cisplatin and pemetrexed for advanced malignant pleural mesothelioma has completed, with results posted in Ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• Alimta (pemetrexed)
• CISPLATIN (cisplatin)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Mesothelioma | Phase 1 | Status: COMPLETED | Results posted: 2024-03-22